145 related articles for article (PubMed ID: 17302548)
1. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy.
Merlo A; Rezende BC; Franchini ML; Simões DM; Lucas SR
J Am Vet Med Assoc; 2007 Feb; 230(4):522-6. PubMed ID: 17302548
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin.
Hahn KA; Freeman KP; Barnhill MA; Stephen EL
J Am Vet Med Assoc; 1999 Apr; 214(7):1023-5. PubMed ID: 10200796
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
Meyer A; Eberle N; Bullerdiek J; Nolte I; Simon D
Vet Comp Oncol; 2010 Jun; 8(2):127-37. PubMed ID: 20579326
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic impact of hypocobalaminemia in dogs with lymphoma.
Cook AK; Wright ZM; Suchodolski JS; Brown MR; Steiner JM
J Am Vet Med Assoc; 2009 Dec; 235(12):1437-41. PubMed ID: 20001778
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
9. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006).
Abbo AH; Lucroy MD
J Am Vet Med Assoc; 2007 Dec; 231(12):1836-42. PubMed ID: 18081522
[TBL] [Abstract][Full Text] [Related]
10. Changes in C-reactive protein and haptoglobin in dogs with lymphatic neoplasia.
Mischke R; Waterston M; Eckersall PD
Vet J; 2007 Jul; 174(1):188-92. PubMed ID: 16901733
[TBL] [Abstract][Full Text] [Related]
11. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
12. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein concentration in dogs with inflammatory leukograms.
Burton SA; Honor DJ; Mackenzie AL; Eckersall PD; Markham RJ; Horney BS
Am J Vet Res; 1994 May; 55(5):613-8. PubMed ID: 8067607
[TBL] [Abstract][Full Text] [Related]
14. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD
J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of serial determinations of lactate dehydrogenase activity used to predict recurrence in dogs with lymphoma.
Marconato L; Crispino G; Finotello R; Mazzotti S; Zini E
J Am Vet Med Assoc; 2010 May; 236(9):969-74. PubMed ID: 20433396
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of lymphoma in 75 cats.
Jeglum KA; Whereat A; Young K
J Am Vet Med Assoc; 1987 Jan; 190(2):174-8. PubMed ID: 3818430
[TBL] [Abstract][Full Text] [Related]
17. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
18. Alimentary lymphoma in cats: 28 cases (1988-1993).
Mahony OM; Moore AS; Cotter SM; Engler SJ; Brown D; Penninck DG
J Am Vet Med Assoc; 1995 Dec; 207(12):1593-8. PubMed ID: 7493898
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein in dogs.
Caspi D; Snel FW; Batt RM; Bennett D; Rutteman GR; Hartman EG; Baltz ML; Gruys E; Pepys MB
Am J Vet Res; 1987 Jun; 48(6):919-21. PubMed ID: 3605808
[TBL] [Abstract][Full Text] [Related]
20. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
Hahn KA; Richardson RC; Teclaw RF; Cline JM; Carlton WW; DeNicola DB; Bonney PL
J Vet Intern Med; 1992; 6(1):3-10. PubMed ID: 1548624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
